MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-24-2025
NovoCure Limited Cost of Revenue 2011-2025 | NVCR
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue NovoCure Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 137 M | 128 M | 115 M | 115 M | 107 M | 88.6 M | 80 M | 55.6 M | 39.9 M | 20.6 M | 10 M | 7.01 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 137 M | 7.01 M | 75.3 M |
Quarterly Cost of Revenue NovoCure Limited
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.5 M | 38.5 M | - | 35.4 M | 34.7 M | 33.7 M | - | 32.1 M | 34 M | 29.6 M | - | 29.7 M | 28.5 M | 27.7 M | - | 30.2 M | 28.6 M | 26.4 M | - | 107 M | 107 M | 107 M | - | 88.6 M | 88.6 M | 88.6 M | - | 80 M | 80 M | 80 M | - | 55.6 M | 55.6 M | 55.6 M | - | 39.9 M | 39.9 M | 39.9 M | - | 20.6 M | 20.6 M | 20.6 M | - | 2.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 107 M | 2.59 M | 49.3 M |
Cost of Revenue of other stocks in the Health care industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cigna Corporation
CI
|
183 B | $ 274.7 | - | $ 75.2 B |  USA |
 |
Anthem
ANTM
|
19.8 B | - | -2.32 % | $ 107 B | USA |
 |
Molina Healthcare
MOH
|
34.4 B | $ 168.5 | - | $ 9.67 B | USA |
 |
Centene Corporation
CNC
|
2.73 B | $ 40.85 | - | $ 21.3 B | USA |
 |
CVS Health Corporation
CVS
|
206 B | $ 79.42 | - | $ 100 B | USA |
 |
UnitedHealth Group Inc.
UNH
|
46.7 B | $ 341.84 | - | $ 315 B | USA |